Expert Opinion on Investigational Drugs , July 2008, Vol. 17, No. 7, Pages 1013-1028.
<br/>
Background: In recent years, several small molecularly–targeted kinase inhibitors have been tested in the clinic for the treatment of cancer. One category of these agents provides selective targeting of a single kinase pathway. More recently, drugs have ...
Read more...
Source:
Expert Opinion: Expert Opinion on Investigational Drugs: Table of Contents
Table of Contents for Expert Opinion on Investigational Drugs. List of articles from both the latest and ahead of print issues.
